AACR Project GENIE 19.0-Public Release

LATEST News

• AACR Project GENIE v19.0-public is now available (271,837 samples / 227,696 patients) with newly added cfDNA samples.
• The Biopharma Collaborative (BPC) Breast v1.0-public (1,130 patients) and Pancreas v1.0-public (1,109 patients) cohorts, containing complete treatments and outcomes data, are now available. Access and visualize via cBioPortal or download from Synapse.
• 2025 was a year of remarkable progress driven by collaboration, innovation, and commitment to advancing precision oncology. 
• On November 6, AACR Project GENIE celebrated 10 years of Powering Precision Cancer Medicine  and Collaborating to Advance Cancer Precision Medicine Globally.
• At the Molecular Targets Meeting in Boston, Massachusetts, sessions highlighted the diverse applications of AACR Project GENIE data, including leveraging clinico-genomic information for research (Ken Kehl, DFCI), examining off-label targeted therapy utilization within GENIE BPC datasets (Jeremy Warner, Brown), and identifying novel drug targets through GENIE data analysis (Phillip Beer, Step Pharma).

• Project GENIE was prominently featured at the AACR Annual Meeting 2025.  

• The latest GENIE publication: Collaborating across sectors in service of open science, precision oncology, and patients: an overview of the AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) Biopharma Collaborative (BPC) – ScienceDirect, Elsevier, Volume 7, March 2025. 

• Watch the Believe in Progress episode: AACR Project GENIE: A Conversation with Shawn M. Sweeney, PhD, and Philippe L. Bedard, MD. 

• New public data portal available from Sage Bionetworks. 

• The BioPharma Collaborative’s CRC v2.0-Public, NSCLC v2.0-Public, BRCA v1.0-public datasets are now available. 

• Learn more about AACR Project GENIE data included as part of sotorasib regulatory approval. 

• Visit the AACR Blog, Cancer Research Catalyst, for more information about AACR Project GENIE®.